These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 18644116

  • 41. HIPK2-a therapeutical target to be (re)activated for tumor suppression: role in p53 activation and HIF-1α inhibition.
    Nardinocchi L, Puca R, Givol D, D'Orazi G.
    Cell Cycle; 2010 Apr 01; 9(7):1270-5. PubMed ID: 20234185
    [Abstract] [Full Text] [Related]

  • 42. How cells switch HIPK2 on and off.
    Sombroek D, Hofmann TG.
    Cell Death Differ; 2009 Feb 01; 16(2):187-94. PubMed ID: 18974774
    [Abstract] [Full Text] [Related]

  • 43. Lenticular cytoprotection, part 2: link between glycogen synthase kinase-3β, epithelial to mesenchymal transition, and mitochondrial depolarization.
    Neelam S, Brooks MM, Cammarata PR.
    Mol Vis; 2014 Feb 01; 20():1758-75. PubMed ID: 25593505
    [Abstract] [Full Text] [Related]

  • 44. Genetic ablation of homeodomain-interacting protein kinase 2 selectively induces apoptosis of cerebellar Purkinje cells during adulthood and generates an ataxic-like phenotype.
    Anzilotti S, Tornincasa M, Gerlini R, Conte A, Brancaccio P, Cuomo O, Bianco G, Fusco A, Annunziato L, Pignataro G, Pierantoni GM.
    Cell Death Dis; 2015 Dec 03; 6(12):e2004. PubMed ID: 26633710
    [Abstract] [Full Text] [Related]

  • 45. Axin stimulates p53 functions by activation of HIPK2 kinase through multimeric complex formation.
    Rui Y, Xu Z, Lin S, Li Q, Rui H, Luo W, Zhou HM, Cheung PY, Wu Z, Ye Z, Li P, Han J, Lin SC.
    EMBO J; 2004 Nov 24; 23(23):4583-94. PubMed ID: 15526030
    [Abstract] [Full Text] [Related]

  • 46. The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.
    Lavra L, Rinaldo C, Ulivieri A, Luciani E, Fidanza P, Giacomelli L, Bellotti C, Ricci A, Trovato M, Soddu S, Bartolazzi A, Sciacchitano S.
    PLoS One; 2011 Nov 24; 6(6):e20665. PubMed ID: 21698151
    [Abstract] [Full Text] [Related]

  • 47. Glucose deprivation increases mRNA stability of vascular endothelial growth factor through activation of AMP-activated protein kinase in DU145 prostate carcinoma.
    Yun H, Lee M, Kim SS, Ha J.
    J Biol Chem; 2005 Mar 18; 280(11):9963-72. PubMed ID: 15640157
    [Abstract] [Full Text] [Related]

  • 48. Glycogen synthase kinase-3 beta regulates Snail and β-catenin expression during Fas-induced epithelial-mesenchymal transition in gastrointestinal cancer.
    Zheng H, Li W, Wang Y, Liu Z, Cai Y, Xie T, Shi M, Wang Z, Jiang B.
    Eur J Cancer; 2013 Aug 18; 49(12):2734-46. PubMed ID: 23582741
    [Abstract] [Full Text] [Related]

  • 49. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ, Park JS, Um SJ.
    J Biol Chem; 2002 Aug 30; 277(35):32020-8. PubMed ID: 11925430
    [Abstract] [Full Text] [Related]

  • 50. Nuclear GSK-3beta inhibits the canonical Wnt signalling pathway in a beta-catenin phosphorylation-independent manner.
    Caspi M, Zilberberg A, Eldar-Finkelman H, Rosin-Arbesfeld R.
    Oncogene; 2008 Jun 05; 27(25):3546-55. PubMed ID: 18223684
    [Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Zyxin is a critical regulator of the apoptotic HIPK2-p53 signaling axis.
    Crone J, Glas C, Schultheiss K, Moehlenbrink J, Krieghoff-Henning E, Hofmann TG.
    Cancer Res; 2011 Mar 15; 71(6):2350-9. PubMed ID: 21248071
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56. Ginkgo biloba exocarp extracts inhibits angiogenesis and its effects on Wnt/β-catenin-VEGF signaling pathway in Lewis lung cancer.
    Han D, Cao C, Su Y, Wang J, Sun J, Chen H, Xu A.
    J Ethnopharmacol; 2016 Nov 04; 192():406-412. PubMed ID: 27649680
    [Abstract] [Full Text] [Related]

  • 57. Homeodomain interacting protein kinase 2 promotes apoptosis by downregulating the transcriptional corepressor CtBP.
    Zhang Q, Yoshimatsu Y, Hildebrand J, Frisch SM, Goodman RH.
    Cell; 2003 Oct 17; 115(2):177-86. PubMed ID: 14567915
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Programmed cell death 4 protein (Pdcd4) and homeodomain-interacting protein kinase 2 (Hipk2) antagonistically control translation of Hipk2 mRNA.
    Ohnheiser J, Ferlemann E, Haas A, Müller JP, Werwein E, Fehler O, Biyanee A, Klempnauer KH.
    Biochim Biophys Acta; 2015 Jul 17; 1853(7):1564-73. PubMed ID: 25820028
    [Abstract] [Full Text] [Related]

  • 60. HIPK2 catalytic activity and subcellular localization are regulated by activation-loop Y354 autophosphorylation.
    Siepi F, Gatti V, Camerini S, Crescenzi M, Soddu S.
    Biochim Biophys Acta; 2013 Jun 17; 1833(6):1443-53. PubMed ID: 23485397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.